Start for free

Indegene Limited

NSE: INDGNHealthcare

Indegene Limited Share Price & Analysis

₹601.50+0.22%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹601.50+0.22%
Open
₹603.70
High
₹611.40
Low
₹598.30
Close
₹601.50
52W High
₹616.00
52W Low
₹414.00
Volume
805K
Lot Size
1
Sector
Healthcare
Market Cap
₹14K Cr
Face Value
₹2
Mid CapNIFTY 500Nifty Smallcap 250

Price Chart

Candle
Range

Fundamentals

P/E
34.80
Sector P/E
54.70
P/B
3.97
EPS
₹16.62
ROE
14.40%
ROCE
18.80%
D/E Ratio
0.05
Div Yield
0.37%
Book Value
₹130.00

Strengths

  • Efficient capital deployment (ROCE 18.8%)
  • Attractively valued vs sector (P/E 34.8x vs industry 54.7x)
  • Virtually debt-free

Concerns

  • Trading near 52-week high (₹616)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,899
₹4.6L Cr36.15.461620.50.07
DIVISLAB
Divi's Laboratories Limited
₹9,100
₹2.4L Cr81.114.4216.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹4,857
₹1.8L Cr82.819.5827.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,650
₹1.2L Cr59.113.1321.217.40.88
CIPLA
Cipla Limited
₹1,385
₹1.1L Cr31.33.2511.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,120
₹1.1L Cr234.1621.221.10.38
LAURUSLABS
Laurus Labs Limited
₹1,840
₹99K Cr90.918.7418.317.80.46

Showing 7 peers in the same sector · Sorted by market cap

Corporate Events

Dividend - Rs 2.25 Per Share

Dividend30 Jul 2026

To consider and approve the financial results for the period ended Jun 30, 2026

Results29 Jul 2026

Dividend - Rs 2 Per Share

Dividend12 Jun 2025

Annual General Meeting

AGM28 Aug 2024

Latest News

All news

Indegene hosts analyst and investor meet.

*Indegene hosts analyst and investor meet.* The company provided updates during its recent investor interaction. No major financial announcements or guidance revisions were disclosed. The session focused on business operations and market positioning. 📊 *STOCKS:* $IDEGENE | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #AnalystMeet

NSE Filing6 Aug
Low Impact

Indegene hosts analyst and investor meet

*Indegene hosts analyst and investor meet* to discuss business updates and strategy. The company shared recordings of the session for investor access. No new financial data or guidance was disclosed. This event is informational in nature with no immediate market-moving triggers. 📊 *STOCKS:* $IDEGENE | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AnalystMeet

NSE Filing31 Jul
Low Impact

Indegene to host analyst and investor meet

*Indegene to host analyst and investor meet.* The company has announced a schedule for its upcoming analyst and institutional investor call. Details on business performance and strategy may be discussed. No major financial announcements or operational updates were disclosed. 📊 *STOCKS:* INDEGENE | 🏢 *SECTOR:* Corporate | #LOWIMPACT #InvestorMeet

NSE Filing10 Jul
Low Impact

Financials

Quarterly Results

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
₹1.0K Cr
6.5%
₹942 Cr
17.2%
₹804 Cr
5.7%
₹761 Cr
0.7%
₹756 Cr
5.0%
₹720 Cr
4.8%
₹687 Cr
1.6%
₹676 Cr
Op. Profit
₹164 Cr
2.5%
₹160 Cr
13.5%
₹141 Cr
9.0%
₹155 Cr
4.7%
₹148 Cr
12.1%
₹132 Cr
4.8%
₹126 Cr
2.3%
₹129 Cr
OPM
16.0%
5.9%
17.0%
0.0%
17.0%
15.0%
20.0%
0.0%
20.0%
11.1%
18.0%
0.0%
18.0%
5.3%
19.0%
Net Profit
₹80 Cr
22.3%
₹103 Cr
1.0%
₹102 Cr
12.1%
₹116 Cr
1.7%
₹118 Cr
7.3%
₹110 Cr
19.6%
₹92 Cr
4.5%
₹88 Cr
EPS (₹)
3.31
22.7%
4.28
0.7%
4.25
12.4%
4.85
1.0%
4.9
7.0%
4.58
19.6%
3.83
4.4%
3.67

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Revenue
₹3.5K Cr
23.6%
₹2.8K Cr
9.6%
₹2.6K Cr
12.3%
₹2.3K Cr
38.5%
₹1.7K Cr
72.4%
₹966 Cr
50.2%
₹643 Cr
16.3%
₹553 Cr
Expenses
₹2.9K Cr
26.2%
₹2.3K Cr
10.0%
₹2.1K Cr
9.1%
₹1.9K Cr
38.6%
₹1.4K Cr
87.2%
₹736 Cr
47.5%
₹499 Cr
2.3%
₹511 Cr
Op. Profit
₹619 Cr
13.0%
₹548 Cr
8.5%
₹505 Cr
27.5%
₹396 Cr
38.0%
₹287 Cr
24.8%
₹230 Cr
59.7%
₹144 Cr
242.9%
₹42 Cr
OPM
18.0%
5.3%
19.0%
5.0%
20.0%
17.6%
17.0%
0.0%
17.0%
29.2%
24.0%
9.1%
22.0%
175.0%
8.0%
Other Income
₹52 Cr
44.7%
₹94 Cr
19.0%
₹79 Cr
36.2%
₹58 Cr
376.2%
₹-21 Cr
600.0%
₹-3 Cr
97.1%
₹-102 Cr
1557.1%
₹7 Cr
Interest
₹19 Cr
13.6%
₹22 Cr
55.1%
₹49 Cr
58.1%
₹31 Cr
416.7%
₹6 Cr
14.3%
₹7 Cr
22.2%
₹9 Cr
50.0%
₹6 Cr
Depreciation
₹126 Cr
57.5%
₹80 Cr
5.3%
₹76 Cr
26.7%
₹60 Cr
81.8%
₹33 Cr
26.9%
₹26 Cr
36.8%
₹19 Cr
11.8%
₹17 Cr
PBT
₹525 Cr
2.6%
₹539 Cr
17.4%
₹459 Cr
26.4%
₹363 Cr
60.6%
₹226 Cr
15.9%
₹195 Cr
1292.9%
₹14 Cr
46.2%
₹26 Cr
Tax %
24.0%
4.0%
25.0%
7.4%
27.0%
0.0%
27.0%
3.6%
28.0%
21.7%
23.0%
88.0%
191.0%
324.4%
45.0%
Net Profit
₹401 Cr
1.5%
₹407 Cr
20.8%
₹337 Cr
26.7%
₹266 Cr
63.2%
₹163 Cr
9.4%
₹149 Cr
1341.7%
₹-12 Cr
185.7%
₹14 Cr
EPS (₹)
16.65
1.8%
16.95
12.0%
15.14
26.3%
11.99
98.7%
937.73
1.5%
951.96
2468.1%
-40.2
144.7%
89.98
Div Payout
13.0%
8.3%
12.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Liabilities
Equity Capital
₹48 Cr
0.0%
₹48 Cr
9.1%
₹44 Cr
0.0%
₹44 Cr
12471.4%
₹0.35 Cr
12.9%
₹0.31 Cr
0.0%
₹0.31 Cr
0.0%
₹0.31 Cr
Reserves
₹3.1K Cr
20.4%
₹2.6K Cr
85.4%
₹1.4K Cr
35.8%
₹1.0K Cr
33.5%
₹764 Cr
135.8%
₹324 Cr
408.6%
₹-105 Cr
243.8%
₹73 Cr
Borrowings
₹144 Cr
41.2%
₹102 Cr
79.2%
₹490 Cr
2.4%
₹502 Cr
660.6%
₹66 Cr
29.4%
₹51 Cr
89.4%
₹483 Cr
228.6%
₹147 Cr
Other Liabilities
₹1.3K Cr
119.5%
₹609 Cr
2.9%
₹627 Cr
1.7%
₹638 Cr
21.8%
₹524 Cr
138.2%
₹220 Cr
0.9%
₹222 Cr
105.6%
₹108 Cr
Total Liabilities
₹4.6K Cr
38.9%
₹3.3K Cr
30.6%
₹2.5K Cr
15.5%
₹2.2K Cr
62.9%
₹1.4K Cr
127.0%
₹596 Cr
0.7%
₹600 Cr
82.4%
₹329 Cr
Assets
Fixed Assets
₹1.8K Cr
167.3%
₹678 Cr
5.0%
₹646 Cr
2.7%
₹664 Cr
381.2%
₹138 Cr
60.5%
₹86 Cr
27.7%
₹119 Cr
14.4%
₹104 Cr
CWIP
₹12 Cr
200.0%
₹4 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
₹0 Cr
Investments
₹1.1K Cr
14.7%
₹1.3K Cr
62.1%
₹796 Cr
29.6%
₹614 Cr
411.7%
₹120 Cr
₹0 Cr
100.0%
₹13 Cr
₹0 Cr
Other Assets
₹1.7K Cr
25.2%
₹1.4K Cr
22.8%
₹1.1K Cr
19.1%
₹926 Cr
15.5%
₹1.1K Cr
114.9%
₹510 Cr
9.0%
₹468 Cr
108.0%
₹225 Cr
Total Assets
₹4.6K Cr
38.9%
₹3.3K Cr
30.6%
₹2.5K Cr
15.5%
₹2.2K Cr
62.9%
₹1.4K Cr
127.0%
₹596 Cr
0.7%
₹600 Cr
82.4%
₹329 Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operating CF
₹651 Cr
47.3%
₹442 Cr
13.0%
₹508 Cr
290.8%
₹130 Cr
56.2%
₹297 Cr
72.7%
₹172 Cr
681.8%
₹22 Cr
66.2%
₹65 Cr
Investing CF
₹-508 Cr
25.0%
₹-677 Cr
107.7%
₹-326 Cr
63.6%
₹-896 Cr
467.1%
₹-158 Cr
95.1%
₹-81 Cr
406.3%
₹-16 Cr
11.1%
₹-18 Cr
Financing CF
₹-83 Cr
128.8%
₹288 Cr
536.4%
₹-66 Cr
119.8%
₹333 Cr
42.9%
₹233 Cr
276.5%
₹-132 Cr
197.1%
₹136 Cr
747.6%
₹-21 Cr
Net Cash Flow
₹60 Cr
15.4%
₹52 Cr
54.8%
₹115 Cr
126.6%
₹-433 Cr
216.1%
₹373 Cr
1032.5%
₹-40 Cr
128.0%
₹143 Cr
472.0%
₹25 Cr
Free Cash Flow
₹606 Cr
47.1%
₹412 Cr
17.1%
₹497 Cr
347.7%
₹111 Cr
59.2%
₹272 Cr
80.1%
₹151 Cr
843.8%
₹16 Cr
66.7%
₹48 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debtor Days
102d
5.2%
97d
6.6%
91d
10.8%
102d
5.2%
97d
10.2%
108d
15.0%
127d
111.7%
60d
Inventory Days
—
—
—
—
—
—
—
—
Days Payable
—
—
—
—
—
—
—
—
Cash Conv. Cycle
102d
5.2%
97d
6.6%
91d
10.8%
102d
5.2%
97d
10.2%
108d
15.0%
127d
111.7%
60d
Working Capital Days
5d
87.2%
39d
44.4%
27d
34.1%
41d
272.7%
11d
75.6%
45d
1000.0%
-5d
28.6%
-7d
ROCE
19.0%
24.0%
25.0%
13.8%
29.0%
12.1%
33.0%
28.3%
46.0%
16.4%
55.0%
48.6%
37.0%
—

Source: Screener.in · Lower days = better efficiency

About Indegene Limited

Incorporated in 1998, Indegene Ltd provides solutions consisting of analytics, technology and commercial, medical, regulatory and safety services to life science and health care organizations[1]

HealthcareHealthcare Services

Related Analysis

Same Sector

ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

Frequently Asked Questions

What is Indegene Limited share price today?
Indegene Limited (INDGN) is currently trading at ₹601.5 on NSE, up 0.22% as of the last market session. Prices update daily after market close on MarketNetra.
Is Indegene Limited available in F&O (Futures & Options)?
Yes, Indegene Limited (INDGN) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Indegene Limited 52-week high and low?
Indegene Limited's 52-week high is ₹616 and the 52-week low is ₹414. The current price of ₹601.5 is 2.4% below the 52W high.
What is Indegene Limited P/E ratio?
Indegene Limited's current P/E ratio is 34.8. This indicates the market is paying ₹34.8 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Indegene Limited options?
Indegene Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade INDGN options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.